Report copyright - Clinical Review (Simponi) · 2018-01-19 · Clinical Review Rachel L. Glaser, MD BLA 125289, Supplement 133 Simponi (Subcutaneous Golimumab) 1 Recommendations/Risk Benefit Assessment
Please pass captcha verification before submit form